Yu Qi
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Extracellular vesicles in disease
- RNA Research and Splicing
- Glycosylation and Glycoproteins Research
Papers in
-
- Cancer-related molecular mechanisms research 16
- Cancer, Hypoxia, and Metabolism 4
- MicroRNA in disease regulation 3
-
- RNA modifications and cancer 12
- Circular RNAs in diseases 7
- RNA Research and Splicing 3
- Co-authors
- Yiran Huang (6 shared papers)Shuangda Li (6 shared papers)Bing Liu (3 shared papers)Dengyan Zhu (5 shared papers)Chun‐yang Zhang (5 shared papers)Kai Wu (5 shared papers)Donglei Liu (5 shared papers)Jia Li (2 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Frontiers in Oncology (2 papers)Frontiers in Cell and Developmental Biology (1 paper)Biomarkers in Medicine (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yu Qi
32 papers receiving 898 citations
Peers
Comparison fields: 5 of 73
- Cancer Research 550
- Molecular Biology 573
- Drug Discovery 1
- Immunology 82
- Pulmonary and Respiratory Medicine 74
Countries citing papers authored by Yu Qi
This map shows the geographic impact of Yu Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Qi more than expected).
Fields of papers citing papers by Yu Qi
This network shows the impact of papers produced by Yu Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Qi. The network helps show where Yu Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 122 | |
| 2 | 2019 | 64 | |
| 3 | 2014 | 61 | |
| 4 | 2016 | 61 | |
| 5 | 2016 | 55 | |
| 6 | 2019 | 54 | |
| 7 | 2021 | 47 | |
| 8 | 2021 | 42 | |
| 9 | 2020 | 41 | |
| 10 | Circulating microRNAs in esophageal squamous cell carcinoma: association with locoregional staging and survival. | 2015 | 41 |
| 11 | 2019 | 39 | |
| 12 | 2012 | 30 | |
| 13 | 2016 | 29 | |
| 14 | 2020 | 23 | |
| 15 | 2022 | 22 | |
| 16 | 2007 | 22 | |
| 17 | 2018 | 17 | |
| 18 | 2019 | 16 | |
| 19 | Plasma microRNAs to predict the response of radiotherapy in esophageal squamous cell carcinoma patients. | 2015 | 16 |
| 20 | 2021 | 16 |
About Yu Qi
Yu Qi is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Plant Science, having authored 36 papers that have together received 907 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (16 papers), RNA modifications and cancer (12 papers), Circular RNAs in diseases (7 papers), Cancer, Hypoxia, and Metabolism (4 papers), Ferroptosis and cancer prognosis (3 papers), RNA Research and Splicing (3 papers), MicroRNA in disease regulation (3 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Cancer Research (550 citations), Molecular Biology (573 citations), Drug Discovery (1 citation), Immunology (82 citations) and Pulmonary and Respiratory Medicine (74 citations). Yu Qi has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yiran Huang, Shuangda Li, Bing Liu, Dengyan Zhu, Chun‐yang Zhang, Kai Wu, Donglei Liu, Jia Li, Qianqian Liu and Shimeng Pan. Their work appears in journals such as Biomedicine & Pharmacotherapy, Journal of Experimental & Clinical Cancer Research, Frontiers in Oncology, Frontiers in Cell and Developmental Biology and Biomarkers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.